INVITRO SUSCEPTIBILITIES OF SUCROSE-NEGATIVE CANDIDA-TROPICALIS, CANDIDA-LUSITANIAE, AND CANDIDA-NORVEGENSIS TO AMPHOTERICIN-B, 5-FLUOROCYTOSINE, MICONAZOLE, AND KETOCONAZOLE

被引:31
作者
AHEARN, DG
MCGLOHN, MS
机构
关键词
D O I
10.1128/JCM.19.3.412-416.1984
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:412 / 416
页数:5
相关论文
共 16 条
  • [11] CHARACTERIZATION OF ATYPICAL CANDIDA-TROPICALIS AND OTHER UNCOMMON CLINICAL YEAST ISOLATES
    SCHLITZER, RL
    AHEARN, DG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 15 (03) : 511 - 516
  • [12] PRIMARY SITE OF ACTION OF KETOCONAZOLE ON CANDIDA-ALBICANS
    UNO, J
    SHIGEMATSU, ML
    ARAI, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (06) : 912 - 918
  • [13] VANCUTSEM J, 1981, MYKOSEN, V24, P596
  • [14] INVITRO AND INVIVO EFFECTS OF THE ANTI-MYCOTIC DRUG KETOCONAZOLE ON STEROL SYNTHESIS
    VANDENBOSSCHE, H
    WILLEMSENS, G
    COOLS, W
    CORNELISSEN, F
    LAUWERS, WF
    VANCUTSEM, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (06) : 922 - 928
  • [15] VANDENBOSSCHE H, 1975, SABOURAUDIA, V13, P63
  • [16] CANDIDA-TROPICALIS - MAJOR PATHOGEN IN IMMUNOCOMPROMISED PATIENTS
    WINGARD, JR
    MERZ, WG
    SARAL, R
    [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (04) : 539 - 543